Seattle Children's Hospital Research Institute  Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on October 23, 2007, 10.1073/pnas.0708710104
PNAS | October 30, 2007 | vol. 104 | no. 44 | 17500-17505


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Related articles in PNAS
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talalay, P.
Right arrow Articles by Dinkova-Kostova, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talalay, P.
Right arrow Articles by Dinkova-Kostova, A. T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

BIOLOGICAL SCIENCES / MEDICAL SCIENCES
Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation

Paul Talalay{dagger},{ddagger}, Jed W. Fahey{dagger},§, Zachary R. Healy{dagger}, Scott L. Wehage{dagger}, Andrea L. Benedict{dagger}, Christine Min{dagger}, and Albena T. Dinkova-Kostova{dagger}

{dagger}Lewis B. and Dorothy Cullman Cancer Chemoprotection Center, Department of Pharmacology and Molecular Sciences, Division of Clinical Pharmacology, Department of Medicine, School of Medicine, and §Department of International Health, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD 21205

Contributed by Paul Talalay, September 13, 2007 (received for review September 10, 2007)

UV radiation (UVR) is a complete carcinogen that elicits a constellation of pathological events, including direct DNA damage, generation of reactive oxidants that peroxidize lipids and damage other cellular components, initiation of inflammation, and suppression of the immune response. Recent dramatic increases in the incidence of nonmelanoma skin cancers are largely attributable to higher exposure of an aging population to UVR. Therefore, the development of cellular strategies for intrinsic protection of the skin against the deleterious effects of UVR is imperative. Here we show that erythema resulting from UVR is a comprehensive and noninvasive biomarker for assessing UVR damage and can be precisely and easily quantified in human skin. Topical application of sulforaphane-rich extracts of 3-day-old broccoli sprouts up-regulated phase 2 enzymes in the mouse and human skin, protected against UVR-induced inflammation and edema in mice, and reduced susceptibility to erythema arising from narrow-band 311-nm UVR in humans. In six human subjects (three males and three females, 28–53 years of age), the mean reduction in erythema across six doses of UVR (300–800 mJ/cm2 in 100 mJ/cm2 increments) was 37.7% (range 8.37–78.1%; P = 0.025). This protection against a carcinogen in humans is catalytic and long lasting.

erythema | nicotinamide:quinone oxidoreductase 1 | skin tumor | chemoprotection


Author contributions: P.T. and A.T.D.-K. designed research; J.W.F., S.L.W., A.L.B., C.M., and A.T.D.-K. performed research; J.W.F. contributed new reagents/analytic tools; P.T., J.W.F., Z.R.H., A.L.B., and A.T.D.-K. analyzed data; and P.T., Z.R.H., and A.T.D.-K. wrote the paper.

Conflict of interest statement: P.T. and J.W.F. are unpaid consultants to Brassica Protection Products, LLC (BPP), which licenses the technology to produce broccoli sprouts from The Johns Hopkins University. P.T., J.W.F., and The Johns Hopkins University are equity owners in BPP (whose chief executive officer is Antony Talalay, son of P.T.), and their stock is subject to certain restrictions under university policy. The terms of this arrangement are being managed by The Johns Hopkins University in accordance with its conflict of interest policies.

{ddagger}To whom all correspondence should be addressed. E-mail: ptalalay{at}jhmi.edu

© 2007 by The National Academy of Sciences of the USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?

Related articles in PNAS:

In This Issue

PNAS 2007 104: 17241-17242. [Full Text]  



This article has been cited by other articles in HighWire Press-hosted journals:


Home page
Journal Watch DermatologyHome page
Another Reason to Get Your Vegetables
Journal Watch Dermatology, November 9, 2007; 2007(1109): 2 - 2.
[Full Text]